sf 6,5 has been researched along with concanavalin a in 3 studies
Studies (sf 6,5) | Trials (sf 6,5) | Recent Studies (post-2010) (sf 6,5) | Studies (concanavalin a) | Trials (concanavalin a) | Recent Studies (post-2010) (concanavalin a) |
---|---|---|---|---|---|
7 | 0 | 0 | 17,959 | 82 | 1,337 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aeed, H; Bruck, R; Greenspoon, N; Halpern, Z; Hershkoviz, R; Lider, O | 1 |
Aeed, H; Bruck, R; Halpern, Z; Hershkoviz, R; Kenet, G; Lider, O; Matas, Z; Shirin, H; Zaidel, L | 1 |
Aeed, H; Bruck, R; Halpern, Z; Hershkoviz, R; Lider, O; Shirin, H | 1 |
1 review(s) available for sf 6,5 and concanavalin a
Article | Year |
---|---|
Non-peptidic analogs of the cell adhesion motif RGD prevent experimental liver injury.
Topics: Animals; Carcinogens; Concanavalin A; Disease Progression; Guanidines; Hepatitis, Autoimmune; Liver Cirrhosis, Experimental; Mice; Mitogens; Oligopeptides; Rats; Receptors, Immunologic; T-Lymphocytes; Thioacetamide; Transaminases; Tumor Necrosis Factor-alpha; Valerates | 2000 |
2 other study(ies) available for sf 6,5 and concanavalin a
Article | Year |
---|---|
Treatment of immune cell-mediated liver damage by nonpeptidic mimetics of the extracellular matrix-associated Arg-Gly-Asp epitope.
Topics: Animals; Cell Adhesion; Concanavalin A; Epitopes; Extracellular Matrix; Fibronectins; Guanidines; Immunity, Cellular; Laminin; Liver; Male; Mice; Mice, Inbred BALB C; Molecular Mimicry; Oligopeptides; Receptors, Immunologic; T-Lymphocytes; Valerates | 1995 |
Analysis of Arg-Gly-Asp mimetics and soluble receptor of tumour necrosis factor as therapeutic modalities for concanavalin A induced hepatitis in mice.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Concanavalin A; Guanidines; Hepatitis, Animal; Interleukin-6; Male; Mice; Mice, Inbred BALB C; Receptors, Tumor Necrosis Factor; Recombinant Proteins; Tumor Necrosis Factor-alpha; Valerates | 1997 |